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Abstract

The objective of this project is to develop an in vivo colorectal cancer (CRC) model in Drosophila
melanogaster to test the role of Ras and Wnt pathways in gastrointestinal cancer as potential therapeutic
targets. To do so, we have (a) developed a CRC model in flies, (b) tested the levels of Ras and Wnt
pathway activity in this model, and (c) will use drugs to find inhibitors of these pathways.
Using fly mutants and transgenic flies we have created small patches of cancerous cells in the fly intestine
in which have activated oncogenic Ras (mutation RasV12) and dominant negative p53 (mutation
UASp53H15N) together with loss of function of APC using mosaic techniques. This model allows evaluation
of multiple genetic combinations (one-, two-, or three- hit models) to evaluate the induced tumor, its
growth profile and the effect of the drug on tumor growth.
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Introduction
Colorectal cancer (CRC) is the third most diagnosed cancer in the world, accounting for
11% of all cancer diagnoses (Rawla, 2019). Among these patients, mutations in genes
adenomatous polyposis coli (APC), p53, and the Ras family are frequently found.
Inactivating mutations in APC have been reported in 34-70% of cases (Luchtenborg,
2004), and result in activation of Wnt via truncated APC proteins (Zhang, 2017).
Oncogenic Ras is observed in approximately 52% of CRC cases, and overactivation
results in the constitutive activation of the Ras pathway, which controls cell growth and
proliferation (Fernandez-Medarde, 2011). Additionally, Ras is a negative regulator of the
Hippo pathway, which regulates tissue size and leads to constitutive activation of
transcription factors YAP and TAZ (Barron, 2014). Finally, loss of p53 or mutations
causing dominant negative p53 are also associated with CRC that shows increased
metastatic or invasive behavior (Li, 2015). P53 is a tumor suppressor gene, so dominant
negative activation results in unregulated death and division of the cells.
Although these mutations are frequently reported, the combination of these genetic
alterations that generate the tumors that show metastatic growth and cause organ
disruption remain poorly understood. Therefore, we have chosen to produce a three-hit
model that incorporates these three mutations to affect different aspects of cell
proliferation. This model can then be studied in multiple genetic combinations of these
affected pathways to isolate the effects of one as a control and study its interactions with
the other two mutations.
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Literature Review
Colorectal cancer (CRC) is the second most common cause of cancer death in the United
States, with an estimated 147,950 new cases in 2020 (Siegel, 2020). Globally, it is the
third deadliest cancer, and the fourth most diagnosed (Rawla, 2019).
Those most at risk include those with family history of colorectal cancer; Black,
American Indian, and Alaska Native adults; and those with risk factors such as obesity,
smoking, diabetes, or unhealthy alcohol use. Worldwide, incidence of CRC is higher in
Western countries and has increased steadily in developing countries adopting the
“western” lifestyle that features a sedentary lifestyle, red meat consumption, obesity,
alcohol, and tobacco (Rawla, 2019). However, age is the most significant risk factor, as
94% of new cases of colorectal cancer occur in adults 45 years or older (US Preventive
Services Task Force, 2021). For this reason, the US Preventive Services Task Force
(USPSTF) recommends that all adults aged 45 or older be offered regular screening.
Screening in the United States has increased 4.4% since 2018, but still leaves 26% of
eligible adults unscreened and 31% overdue (US Preventive Services Task Force, 2021).
Most common screening methods are divided into two categories: stool-based tests and
direct visualization tests. Stool-based tests include guaiac fecal occult blood test
(gFOBT), fecal immunochemical test (FIT), and stool DNA test. Direct visualization tests
include colonoscopy, CT colonography, and flexible sigmoidoscopy. To maximize lifeyears gained and decrease colorectal cancer cases and deaths, the USPSTF recommends
screening in one or more of these combinations of intervals: gFOBT or FIT every year,
sDNA-FIT every 1-3 years, CT colonography or flexible sigmoidoscopy every 5 years,
flexible sigmoidoscopy every 10 years with a FIT every year, and/or colonoscopy
screening every 10 years.
Following a positive screening, treatment may vary based on severity of the cancer. If
potentially curable, the patient may undergo surgery; in advanced cases, chemotherapy
may improve and maintain quality of life (Labianca, 2010). Both treatment options are
invasive and target healthy cells as well as cancerous ones. Therefore, it is imperative to
find therapeutic targets for less invasive and more effective treatment.
The research question explored by this project is to identify these targets through
studying the cooperative interactions between Wnt and Ras resulting in intestinal
hyperplasia in Drosophila melanogaster. Using the escGAL4 system, a driver specific to
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intestinal stem cells (ISCs), new fly lines
were created with manipulated p53
dominant negative and Ras-activated
alleles in the intestine.
Drosophila were chosen for this model
due to the potential to apply findings to
higher vertebrate models because of
similarity in intestinal tissue composition
and molecular pathway conservation.
Like the mammalian intestine, the
Drosophila adult intestinal epithelium
(Figure 1) is highly proliferative because
it contains active, inactive, and dormant
stem cells. There is also a considerable
Figure 1: Intestinal structure of mammals amount of overlap in the molecular
and Drosophila. (Apidianakis, 2011)
pathways they share with humans. For
example, the molecular nature of the Hippo pathway was discovered through genetic
screens of Drosophila, and this pathway is strongly conserved in humans. (Barron, 2014).
In addition, their quick repopulation time, high fecundity, and short life cycle allows for
generations of genetic testing and timely results in adult models, as well as the possibility
of creating a specific genetic model type. Other benefits include their ability to ingest
cancer drugs in vivo, available array of genetic tools, and the ability to manipulate genes
in defined cell types. Fruit flies are an effective preclinical model, as some phase I and II
clinical trials have been successful based on fly genetic modeling of tumors.
The genes manipulated in this model to induce the constitutive activation of Ras/MAPK
and Wnt and negative regulation of Hippo are as follows: p53, to undergo dominant
negative mutation p55 ; Ras, to undergo mutation Ras ; and APC, to undergo mutation
82Bapc1apc2. Gene expression is manipulated with escGAL4. In healthy cells, p53 is a
tumor suppressor gene, promoting programmed cell death and division. Inducing loss of
function by activating a dominant negative form of this gene will lead to an over
proliferation of cells. Normally functioning Ras produces Ras signaling proteins to drive
cell growth and proliferation through the Ras pathway (Figure 2), while overactivation
will excessively promote stem cell division (Saeed, 2019 and Asha, 2003). Finally,
healthy APC is a tumor suppressor gene serving multiple functions, involved in processes
related to cell migration, cell adhesion, proliferation, differentiation, and chromosome
segregation. Inducing loss of function leads to constitutive activation of the Wnt
signaling pathway (Zhang, 2017).
H159N
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Figure 2: (left)
Ras signaling
pathway
(Gimple, 2019)

Figure 3:
(right) Hippo
pathway in
Drosophila
(Wang, 2018)
The Hippo and Wnt pathways are useful targets for their role in homeostasis and
regeneration of gastrointestinal tissues. These were mentioned in the introduction as
linked to Ras and APC genes respectively. Hippo (Figure 3) is a highly conserved
signaling pathway that controls organ size and tissue growth by utilizing YAP and TAZ.
The canonical Wnt signaling pathway (Figure 4) maintains embryonic and tissue
homeostasis through utilizing B-catenin, a transcriptional coactivator (Majidinia, 2017).
Wnt also plays an essential role in the development and regeneration of the intestinal
epithelium. Overactivation of this pathway results in constitutive activation of B-catenin,
which leads to excessive ISC proliferation. Complex interactions between the Hippo and
Wnt pathways result in altered gene expression of multiple protooncogenes and tumor
suppressor genes (Majidinia, 2017). Since Wnt signaling is activated through B-catenin,
and a transcriptional target of B-catenin is CD44, which has the ability to activate NF2,
Wnt signaling can activate the Hippo pathway (Barron, 2014).
Given the intricate roles of these pathways in development and disease, it is important to
test which variations play a critical and causal role in colorectal cancer. Therefore, we
decided to test the effects of manipulating these pathways in multiple combinations to
assess their specific roles in colorectal cancers using Drosophila. The key findings from
these initial assessments are described in subsequent sections.

Figure 4:
Canonical Wnt
signaling pathway
(Rai, 2022)
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Methods
The fly stocks used for this experiment were obtained from Bloomington Drosophila
Stock Center and cultured on standard yeast-cornemal-agar Drosophila food at 20 C in a
humidity controlled incubator. Starting by crossing genotypes UAS p53 (x) with
w:escGAL4;GAL , w:escGAL4 UAS GFP with UAS p53 (X), and w; escGAL4 UAS
GFP with hsFLP;Sp/CyO;TM3/TM6B, a team of people was able to generate a large
number of crosses to complete progress towards this goal. This involved ensuring that
phenotypic markers were present to select for the correct flies, confirming both parent
flies had the correct gene on both chromosomes, or including green fluorescent protein
(GFP) so that activity can be noted under a microscope.
o

H159N

80ts

H159N

Flies were maintained by transferring adult flies every third day into a new labeled plastic
vial with agar and capped with a cotton ball. All vials were kept for two weeks, resulting
in a 5x5 grid of vials featuring a row with adult flies, eggs, larvae, pupae, and new flies,
which was then replicated in four identical rows. Using this method, different stages of
the Drosophila life cycle can be observed in increasingly older vials.
Mature third instar larvae were collected around day three of the life cycle to undergo
intestinal dissection. Dissections were completed in PBS with size 5 and 55 forceps to
isolate the intestine before fixing it in 150 μL PBS and 50 μL 16% paraformaldehyde for
20 minutes. Samples then underwent two series of 15 minute washings in 1000 μL 1x
PBST. One washing included adding the samples and 1000 μL 1x PBST to a 1.5 mL
microcentrifuge tube, rotating it on the nutator for 15 minutes, and carefully removing the
1x PBST via vacuum while leaving the samples in the 1.5 mL microcentrifuge tube. After
this series of washings were complete, the samples rested in primary antibody Prospero
(dilution 1:100) at 4 C overnight. The amount of antibody added was dependent on the
number of larvae dissected, and was equivalent to half the number of samples in
microliters. The next morning, Prospero was removed and the samples were again
washed twice in 100 μL 1x PBST for 15 minutes each. Secondary antibody mouse Cy3
(dilution 1:250) was then added and the samples were mixed on the nutator covered in
tinfoil for two hours at 20 C. After undergoing a final series of washing in 100 μL 1x
PBST for 15 minutes, the samples were mounted in Vectashield and useful slides were
imaged under a confocal microscope.
o

o
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Results
The following samples were imaged under a confocal microscope. Red fluorescence
indicates Prospero bound to the nuclei of enteroendocrine cells, green fluorescence is due
to the presence of green fluorescent protein (GFP) and indicates escGAL4-activated gene
expression, and yellow fluorescence indicates a combination of the two.

Figure 5: Parental genotypes of UASp55

H159N

(left) and UAS Ras (right).
V12

Figure 6: F1 genotype of escGAL4 expressed UAS
, result of experiment 1. The
middle image displays only Prospero fluorescence, the right image displays only GFP+
cells, and the left image displays the two overlapping.
p53H159N
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Figure 7: F1 genotype of escGAL4 expressed Ras , result of experiment 2. The middle
image displays only Prospero fluorescence, the right image displays only GFP+ cells, and
the left image displays the two overlapping.
V12
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Discussion
Because intestinal stem cells (ISCs) have the
potential to differentiate into any other type of cell,
they are often dysregulated in cancers and
therefore a useful target for identifying and
measuring tissue proliferation. The epithelium of
the colon contains four different cell lineages:
enterocytes, goblet cells, endocrine cells, and
Paneth cells (Munro, 2018). These all arise from
ISCs at the base of crypts (Figure 8), known as
crypt base columnar cells (CBCs). Once these cells
lose control of replication and differentiation, they
become cancer stem cells (CSCs), and lead to
tumorigenesis. This increased unregulated ISC
proliferation can eventually result in intestinal
Figure 8: Anatomy of the intestinal
polyposis and colon cancer (Majidinia, 2017).
epithelium (Munro, 2018)
Drosophila ISCs are distributed evenly throughout the intestine, but with variable
proliferation capacity in different zones. ISCs self-renew and form a transient committed
progenitor cell called enteroblasts (EBs). The EBs differentiate into absorptive enterocyte
(ECs) and enteroendocrine (ee) cells.
The antibody Prospero used in this experiment binds to the nuclei of ee cells, making it
an excellent marker for intestinal stem cell proliferation. Analysis of concentration of
Prospero in controls and progeny shows an increased concentration and density of
distribution of Prospero in p53 progeny and a slightly decreased concentration and
density of distribution of Prospero in RasV12 progeny. This could be due to the area of
the intestine that was imaged, as there is some variability between the midgut and
hindgut.
GFP+ clusters also indicate areas of intestinal stem cell proliferation. Since clusters of
GFP are wider in diameter than spots of Prospero, they could indicate a denser area
composed of multiple ISCs. Significant levels of GFP in the progeny that are not present
in the parent generation indicate successful escGAL4-controlled expression of dominant
negative p53 and RasV12, meaning that it can be used as a measure of p53 and RasV12
activity.
In p53 progeny, yellow autofluorescence is sourced from food in the gut. This can
indicate luminal space and help assess the thickness of the intestinal epithelium in future
experiments and dissections. Colocalization could also indicate the nuclei of ISCs that
Prospero has bound to.
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Conclusion
Significant findings from this project include the creation of a model utilizing escGAL4controlled expression of dominant negative p53 and RasV12. Also noteworthy are the
increased levels of Prospero in RasV12 progeny, decreased levels in p53 progeny, and
clusters of GFP+ cells in both progeny. This means that ISC proliferation occurs in
response to escGAL4 expression and results in clusters in the intestine of the fly.
Next steps for this project could include combining the progeny of experiment 1 and
experiment 2 with the APC mutated flies to finalize the three-hit model. We could then
dissect the combinations of one-, two-, and three-hits integrating the APC mutation. After
studying the survival and progression of these flies throughout the life cycle, we could
test the effect of tumor size, shape, and proliferation in larvae and later as adults. We
could then complete the third aim to identify drugs that inhibit the Ras and Wnt
pathways, and feed larvae target drugs over a range of concentrations.

P a g e | 10

Works Cited
Adams, J., Casali, A., & Campbell, K. (2021). Methods to Generate and Assay for
Distinct Stages of Cancer Metastasis in Adult Drosophila melanogaster. Methods
in molecular biology (Clifton, N.J.), 2179, 161–170. https://doi.org/10.1007/9781-0716-0779-4_14
Apidianakis, Y., Rahme, L.G. (2011). Drosophila melanogaster as a model for human
intestinal infection and pathology. Disease Models and Mechanisms. 4(1): 21-30.
https://doi.org/10.1242/dmm.003970
Asha, H., Nagy, I., Kovacs, G., Stetson, D., Ando, I., & Dearolf, C. R. (2003). Analysis
of Ras-induced overproliferation in Drosophila hemocytes. Genetics, 163(1),
203–215. https://doi.org/10.1093/genetics/163.1.203
Barron, D. A., & Kagey, J. D. (2014). The role of the Hippo pathway in human disease
and tumorigenesis. Clinical and translational medicine, 3, 25.
https://doi.org/10.1186/2001-1326-3-25
Fernández-Medarde, A., & Santos, E. (2011). Ras in cancer and developmental diseases.
Genes & cancer, 2(3), 344–358. https://doi.org/10.1177/1947601911411084
Gimple, R. C., & Wang, X. (2019). Ras: Striking at the core of the oncogenic circuitry.
Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.00965
Hirth F. (2010). Drosophila melanogaster in the study of human neurodegeneration. CNS
& neurological disorders drug targets, 9(4), 504–523.
https://doi.org/10.2174/187152710791556104
Hung, R., Hu, Y., Kirchner, R., Liu, Y., Xu, C., Comjean, A., Tattikota, S., li, F., Song,
W., Sui, S., & Perrimon, N. (2020). A cell atlas of the adult Drosophila midgut.
Proceedings of the National Academy of Sciences of the United States of America,
117(3), 1514-1523. https://doi.org/10.1073/pnas.1916820117
Jin, Y., Ha, N., Forés, M., Xiang, J., Gläßer, C., Maldera, J., Jiménez, G., & Edgar, B. A.
(2015). EGFR/Ras Signaling Controls Drosophila Intestinal Stem Cell
Proliferation via Capicua-Regulated Genes. PLoS genetics, 11(12), e1005634.
https://doi.org/10.1371/journal.pgen.1005634
Labianca, R., Beretta, G. D., Kildani, B., Milesi, L., Merlin, F., Mosconi, S., Pessi, M. A.,
Prochilo, T., Quadri, A., Gatta, G., de Braud, F., & Wils, J. (2010). Colon cancer.
Critical reviews in oncology/hematology, 74(2), 106–133.
https://doi.org/10.1016/j.critrevonc.2010.01.010

P a g e | 11

Li, N., Lu, N., & Xie, C. (2019). The Hippo and Wnt signaling pathways: crosstalk
during neoplastic progression in gastrointestinal tissue. The FEBS journal,
286(19), 3745–3756. https://doi.org/10.1111/febs.15017
Li, X. L., Zhou, J., Chen, Z. R., & Chng, W. J. (2015). P53 mutations in colorectal cancer
- molecular pathogenesis and pharmacological reactivation. World journal of
gastroenterology, 21(1), 84–93. https://doi.org/10.3748/wjg.v21.i1.84
Lüchtenborg, M., Weijenberg, M., Roemen, G., Bruïne, A., Van den Brandt, P., Lentjes,
M., Brink, M., Van Engeland, M., Goldbohm, R., De Goeij, A. (2004). APC
mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study ,
Carcinogenesis, Volume 25, Issue 7, July 2004, Pages 1219–1226,
https://doi.org/10.1093/carcin/bgh117
Martorell Ò, Merlos-Suárez A, Campbell K, Barriga FM, Christov CP, Miguel-Aliaga I,
et al. (2014) Conserved Mechanisms of Tumorigenesis in the Drosophila Adult
Midgut. PLoS ONE 9(2): e88413. https://doi.org/10.1371/journal.pone.0088413
Majidinia, M, Aghazadeh, J, Jahanban-Esfahlani, R, Yousefi, B. (2017). The roles of
Wnt/β-catenin pathway in tissue development and regenerative medicine. J Cell
Physiol. 2018; 233: 5598– 5612. https://doi.org/10.1002/jcp.26265
Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T., & Itinteang, T. (2018).
Cancer stem cells in colorectal cancer: a review. Journal of clinical pathology,
71(2), 110–116. https://doi.org/10.1136/jclinpath-2017-204739
Pinto, N., Carrington, B., Dietrich, C., Sinha, R., Aguilar, C., Chen, T., Aggarwal, P.,
Kango-Singh, M., & Singh, S. R. (2018). Markers and Methods to Study Adult
Midgut Stem Cells. Methods in molecular biology (Clifton, N.J.), 1842, 123–137.
https://doi.org/10.1007/978-1-4939-8697-2_9
Rai, A. (2022). Yorkie-dependent transcriptional network promotes tumor growth. Poster
presented at Brother Joseph W. Stander Symposium.
Rawla, P., Sunkara, T., & Barsouk, A. (2019). Epidemiology of colorectal cancer:
incidence, mortality, survival, and risk factors. Przeglad gastroenterologiczny,
14(2), 89–103. https://doi.org/10.5114/pg.2018.81072
Saeed, O., Lopez-Beltran, A., Fisher, K. W., Scarpelli, M., Montironi, R., Cimadamore,
A., Massari, F., Santoni, M., & Cheng, L. (2019). RAS genes in colorectal
carcinoma: pathogenesis, testing guidelines and treatment implications. Journal of
clinical pathology, 72(2), 135–139. https://doi.org/10.1136/jclinpath-2018205471
Siegel, RL, Miller, KD, Fuchs, HE, Jemal, A. (2022) Cancer statistics, 2022. CA Cancer
J Clin. 2022. https://doi.org/10.3322/caac.21708

P a g e | 12

Sogame, N., Kim, M., & Abrams, J. M. (2003). Drosophila p53 preserves genomic
stability by regulating cell death. Proceedings of the National Academy of
Sciences of the United States of America, 100(8), 4696–4701.
https://doi.org/10.1073/pnas.0736384100
US Preventive Services Task Force. (2021). Screening for Colorectal Cancer: US
Preventive Services Task Force Recommendation Statement. JAMA.
2021;325(19):1965–1977. doi:10.1001/jama.2021.6238
Vidal, M., Cagan, R. (2006). Drosophila models for cancer research. Science Direct
16(1), 10-16. https://doi.org/10.1016/j.gde.2005.12.004
Wang, W. (2018). The Hippo Pathway. University of California, Irvine.
https://faculty.sites.uci.edu/wenqiw6/research/
Zenonos, K., & Kyprianou, K. (2013). RAS signaling pathways, mutations and their role
in colorectal cancer. World journal of gastrointestinal oncology, 5(5), 97–101.
https://doi.org/10.4251/wjgo.v5.i5.97
Zhang, L., & Shay, J. W. (2017). Multiple Roles of APC and its Therapeutic Implications
in Colorectal Cancer. Journal of the National Cancer Institute, 109(8), djw332.
https://doi.org/10.1093/jnci/djw332
Zhang, W., Cohen, S. (2013).The Hippo pathway acts via p53 and microRNAs to control
proliferation and proapoptotic gene expression during tissue growth. Biol Open 15
August 2013; 2 (8): 822–828. doi: https://doi.org/10.1242/bio.20134317

